Larcher C, Huemer H P, Hönlinger M, Margreiter R, Dierich M P
Institut für Hygiene, Universität Innsbruck.
Wien Klin Wochenschr. 1989 Jun 23;101(13):448-50.
Antibodies to HHV-6 were detected by immunofluorescence in 8.04% of 460 healthy blood donors in West Austria. Testing sera from patients with acute or reactivated infections with other herpesviruses, such as cytomegalovirus (CMV), Epstein-Barr virus (EBV), herpes simplex virus (HSV) and varicella zoster virus (VZV) we observed a remarkably higher prevalence of antibodies to HHV-6 in patients with CMV infections (75%) and also in patients with EBV infections (50%). Patients with HSV and VZV infections were positive for HHV 6 in 12.5% and 6.6% of cases, respectively. Many of the patients with CMV infection were transplant recipients. The high incidence of positive HH 6 serology in these patients could be due to new infection by HHV 6 or to the reactivation of a previous infection with HHV 6 by means of allogenic cell stimulation. Furthermore, preliminary results from our laboratory point to a serological cross-reaction between HHV 6 and CMV, which may also contribute to this result.
在奥地利西部的460名健康献血者中,通过免疫荧光法检测到8.04%的人存在针对人疱疹病毒6型(HHV - 6)的抗体。对患有急性或再激活感染其他疱疹病毒(如巨细胞病毒(CMV)、爱泼斯坦 - 巴尔病毒(EBV)、单纯疱疹病毒(HSV)和水痘带状疱疹病毒(VZV))的患者血清进行检测时,我们观察到,CMV感染患者中针对HHV - 6的抗体患病率显著更高(75%),EBV感染患者中也是如此(50%)。HSV和VZV感染患者中,分别有12.5%和6.6%的病例HHV - 6呈阳性。许多CMV感染患者是移植受者。这些患者中HHV - 6血清学阳性的高发生率可能是由于HHV - 6新感染,或者是通过异体细胞刺激使先前感染的HHV - 6重新激活所致。此外,我们实验室的初步结果表明HHV - 6与CMV之间存在血清学交叉反应,这也可能导致了这一结果。